Telcon RF Pharmaceutical is trading at 7,170 KRW as of 12:31 PM on the 16th, down 8.43% from the previous day. This represents a 28.23% decrease compared to September 24. Telcon RF Pharmaceutical is known as a manufacturer of components for wireless communication equipment.
Today, foreigners have a net purchase of 115,000 shares of Telcon RF Pharmaceutical, while institutions have a net sale of 8,000 shares, according to provisional data. Over the past five days, individual investors have net purchased 415,607 shares, while foreigners and institutions have net sold 291,083 shares and 100,300 shares, respectively.
On October 15, Telcon RF Pharmaceutical was a market topic with the headline "Rising on news of Humanigen treatment clinical trials."


※ Source: AI Investment Assistant AI Rassiro
※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
![User Who Sold Erroneously Deposited Bitcoins to Repay Debt and Fund Entertainment... What Did the Supreme Court Decide in 2021? [Legal Issue Check]](https://cwcontent.asiae.co.kr/asiaresize/183/2026020910431234020_1770601391.png)
